These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 17148582)

  • 21. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
    Schubert S; Renner C; Hammer M; Abdul-Khaliq H; Lehmkuhl HB; Berger F; Hetzer R; Reinke P
    J Heart Lung Transplant; 2008 Jan; 27(1):100-5. PubMed ID: 18187094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Horse versus rabbit antithymocyte globulin in acquired aplastic anemia.
    Scheinberg P; Nunez O; Weinstein B; Scheinberg P; Biancotto A; Wu CO; Young NS
    N Engl J Med; 2011 Aug; 365(5):430-8. PubMed ID: 21812672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epstein-Barr virus reactivation in allogeneic stem cell transplantation is highly related to cytomegalovirus reactivation.
    Zallio F; Primon V; Tamiazzo S; Pini M; Baraldi A; Corsetti MT; Gotta F; Bertassello C; Salvi F; Rocchetti A; Levis A
    Clin Transplant; 2013; 27(4):E491-7. PubMed ID: 23781897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Active CMV and EBV infections in renal transplant recipients with unexplained fever and elevated serum creatinine.
    Hasannia T; Moosavi Movahed SM; Vakili R; Rafatpanah H; Hekmat R; Valizadeh N; Rezaee SA
    Ren Fail; 2016 Oct; 38(9):1418-1424. PubMed ID: 27484706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epstein-Barr virus-associated lymphoproliferative disorder developed after anti-thymocyte globulin therapy in a patient with bone marrow failure associated with T-cell large granular lymphocytic leukemia.
    Sumi M; Watanabe M; Sato K; Shimizu I; Ueki T; Akahane D; Ueno M; Ichikawa N; Asano N; Kobayashi H
    Rinsho Ketsueki; 2011 Nov; 52(11):1782-7. PubMed ID: 22185802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monitoring of EBV reactivation is justified in patients with aplastic anemia treated with rabbit ATG as a second course of immunosuppression.
    Wondergem MJ; Stevens SJ; Janssen JJ; Oudejans JJ; Ossenkoppele GJ; Middeldorp JM; Zweegman S
    Blood; 2008 Feb; 111(3):1739; author reply 1739-40. PubMed ID: 18223173
    [No Abstract]   [Full Text] [Related]  

  • 27. The efficacy of rabbit antithymocyte globulin with cyclosporine in comparison to horse antithymocyte globulin as a first-line treatment in adult patients with severe aplastic anemia: a single-center retrospective study.
    Shin SH; Yoon JH; Yahng SA; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Kim HJ; Cho SG; Kim DW; Min WS; Park CW; Lee JW
    Ann Hematol; 2013 Jun; 92(6):817-24. PubMed ID: 23318980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune reconstitution and cytomegalovirus infection after allogeneic stem cell transplantation: the important impact of in vivo T cell depletion.
    Schmidt-Hieber M; Schwarck S; Stroux A; Ganepola S; Reinke P; Thiel E; Uharek L; Blau IW
    Int J Hematol; 2010 Jun; 91(5):877-85. PubMed ID: 20490728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapidly progressive Epstein-Barr virus-associated lymphoproliferative disorder unpredictable by weekly viral load monitoring.
    Wakabayashi S; Ohashi K; Hanajiri R; Kobayashi T; Yamashita T; Akiyama H; Sakamaki H
    Intern Med; 2010; 49(10):931-5. PubMed ID: 20467179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytomegalovirus and Epstein-Barr virus reactivation in the intensive care unit.
    Coşkun O; Yazici E; Şahiner F; Karakaş A; Kiliç S; Tekin M; Artuk C; Yamanel L; Beşirbellioğlu BA
    Med Klin Intensivmed Notfmed; 2017 Apr; 112(3):239-245. PubMed ID: 27435067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epstein-Barr virus associated pneumonia in an adult patient with severe aplastic anaemia: resolution after the transient withdrawal of cyclosporine.
    Potenza L; Barozzi P; Codeluppi M; Morselli M; Forghieri F; Volzone F; Riva G; Pietrosemoli P; Pecorari M; Leonardi G; Torelli G; Luppi M
    Am J Hematol; 2007 Oct; 82(10):944-6. PubMed ID: 17617784
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of severe aplastic anemia with a combination of horse antithymocyte globulin and cyclosporine, with or without sirolimus: a prospective randomized study.
    Scheinberg P; Wu CO; Nunez O; Scheinberg P; Boss C; Sloand EM; Young NS
    Haematologica; 2009 Mar; 94(3):348-54. PubMed ID: 19181786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Valganciclovir prevents cytomegalovirus reactivation in patients receiving alemtuzumab-based therapy.
    O'Brien S; Ravandi F; Riehl T; Wierda W; Huang X; Tarrand J; O'Neal B; Kantarjian H; Keating M
    Blood; 2008 Feb; 111(4):1816-9. PubMed ID: 18039954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of in vivo T cell depletion with alemtuzumab on reduced-intensity allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia.
    Delgado J; Pillai S; Benjamin R; Caballero D; Martino R; Nathwani A; Lovell R; Thomson K; Perez-Simon JA; Sureda A; Kottaridis P; Vazquez L; Peggs K; Sierra J; Milligan D; Mackinnon S
    Biol Blood Marrow Transplant; 2008 Nov; 14(11):1288-97. PubMed ID: 18940684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunosuppressive therapy (IST) in adult patients with acquired aplastic anemia (AA): A single-center experience over the past 15 years.
    Alashkar F; Oelmüller M; Herich-Terhürne D; Turki AT; Schmitz C; Vance C; Dührsen U; Röth A
    Eur J Haematol; 2019 Jul; 103(1):18-25. PubMed ID: 30977158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of response to immunosuppressive therapy with antithymocyte globulin and cyclosporine and prognostic factors for survival in patients with severe aplastic anemia.
    Chang MH; Kim KH; Kim HS; Jun HJ; Kim DH; Jang JH; Kim K; Jung CW
    Eur J Haematol; 2010 Feb; 84(2):154-9. PubMed ID: 19912311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution.
    Chakrabarti S; Mackinnon S; Chopra R; Kottaridis PD; Peggs K; O'Gorman P; Chakraverty R; Marshall T; Osman H; Mahendra P; Craddock C; Waldmann H; Hale G; Fegan CD; Yong K; Goldstone AH; Linch DC; Milligan DW
    Blood; 2002 Jun; 99(12):4357-63. PubMed ID: 12036862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of serum and whole blood levels of cytomegalovirus and Epstein-Barr virus DNA.
    Kullberg-Lindh C; Olofsson S; Brune M; Lindh M
    Transpl Infect Dis; 2008 Oct; 10(5):308-15. PubMed ID: 18466193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Immunosuppressive therapy for 54 children patients with acquired severe aplastic anemia].
    Chen C; Fang JP; Huang SL; Zhong FY
    Zhonghua Er Ke Za Zhi; 2006 Nov; 44(11):841-4. PubMed ID: 17274875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alemtuzumab, fludarabine and melphalan as a conditioning therapy in severe aplastic anemia and hypoplastic myelodysplastic syndrome--single center experience.
    Rzepecki P; Sarosiek T; Szczylik C
    Jpn J Clin Oncol; 2006 Jan; 36(1):46-9. PubMed ID: 16423840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.